254 related articles for article (PubMed ID: 12113946)
1. Quantitative autoradiographic mapping of opioid receptors in the brain of delta-opioid receptor gene knockout mice.
Goody RJ; Oakley SM; Filliol D; Kieffer BL; Kitchen I
Brain Res; 2002 Jul; 945(1):9-19. PubMed ID: 12113946
[TBL] [Abstract][Full Text] [Related]
2. Quantitative autoradiographic mapping of the ORL1, mu-, delta- and kappa-receptors in the brains of knockout mice lacking the ORL1 receptor gene.
Clarke S; Chen Z; Hsu MS; Pintar J; Hill R; Kitchen I
Brain Res; 2001 Jul; 906(1-2):13-24. PubMed ID: 11430857
[TBL] [Abstract][Full Text] [Related]
3. Quantitative autoradiographic mapping of mu-, delta- and kappa-opioid receptors in knockout mice lacking the mu-opioid receptor gene.
Kitchen I; Slowe SJ; Matthes HW; Kieffer B
Brain Res; 1997 Dec; 778(1):73-88. PubMed ID: 9462879
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological and anatomical evidence of selective mu, delta, and kappa opioid receptor binding in rat brain.
Mansour A; Lewis ME; Khachaturian H; Akil H; Watson SJ
Brain Res; 1986 Dec; 399(1):69-79. PubMed ID: 3026574
[TBL] [Abstract][Full Text] [Related]
5. Quantitative autoradiography of mu-,delta- and kappa1 opioid receptors in kappa-opioid receptor knockout mice.
Slowe SJ; Simonin F; Kieffer B; Kitchen I
Brain Res; 1999 Feb; 818(2):335-45. PubMed ID: 10082819
[TBL] [Abstract][Full Text] [Related]
6. Analysis of [3H]bremazocine binding in single and combinatorial opioid receptor knockout mice.
Simonin F; Slowe S; Becker JA; Matthes HW; Filliol D; Chluba J; Kitchen I; Kieffer BL
Eur J Pharmacol; 2001 Mar; 414(2-3):189-95. PubMed ID: 11239918
[TBL] [Abstract][Full Text] [Related]
7. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
Zhao GM; Qian X; Schiller PW; Szeto HH
J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
[TBL] [Abstract][Full Text] [Related]
8. Mu-, delta- and kappa-opioid receptor populations are differentially altered in distinct areas of postmortem brains of Alzheimer's disease patients.
Mathieu-Kia AM; Fan LQ; Kreek MJ; Simon EJ; Hiller JM
Brain Res; 2001 Mar; 893(1-2):121-34. PubMed ID: 11223000
[TBL] [Abstract][Full Text] [Related]
9. Activity of the delta-opioid receptor is partially reduced, whereas activity of the kappa-receptor is maintained in mice lacking the mu-receptor.
Matthes HW; Smadja C; Valverde O; Vonesch JL; Foutz AS; Boudinot E; Denavit-Saubié M; Severini C; Negri L; Roques BP; Maldonado R; Kieffer BL
J Neurosci; 1998 Sep; 18(18):7285-95. PubMed ID: 9736649
[TBL] [Abstract][Full Text] [Related]
10. Comparison of G-protein activation in the brain by mu-, delta-, and kappa-opioid receptor agonists in mu-opioid receptor knockout mice.
Park Y; Ma T; Tanaka S; Jang C; Loh HH; Ko KH; Ho IK
Brain Res Bull; 2000 Jul; 52(4):297-302. PubMed ID: 10856828
[TBL] [Abstract][Full Text] [Related]
11. Autoradiographic distribution of mu-, delta- and kappa 1-opioid stimulated [35S]guanylyl-5'-O-(gamma-thio)-triphosphate binding in human frontal cortex and cerebellum.
Platzer S; Winkler A; Schadrack J; Dworzak D; Tölle TR; Zieglgänsberger W; Spanagel R
Neurosci Lett; 2000 Apr; 283(3):213-6. PubMed ID: 10754225
[TBL] [Abstract][Full Text] [Related]
12. Changes in spinal delta and kappa opioid systems in mice deficient in the A2A receptor gene.
Bailey A; Ledent C; Kelly M; Hourani SM; Kitchen I
J Neurosci; 2002 Nov; 22(21):9210-20. PubMed ID: 12417646
[TBL] [Abstract][Full Text] [Related]
13. Characterization of mu, kappa, and delta opioid binding in amphibian whole brain tissue homogenates.
Newman LC; Sands SS; Wallace DR; Stevens CW
J Pharmacol Exp Ther; 2002 Apr; 301(1):364-70. PubMed ID: 11907194
[TBL] [Abstract][Full Text] [Related]
14. Naloxone and its quaternary derivative, naloxone methiodide, have differing affinities for mu, delta, and kappa opioid receptors in mouse brain homogenates.
Lewanowitsch T; Irvine RJ
Brain Res; 2003 Feb; 964(2):302-5. PubMed ID: 12576191
[TBL] [Abstract][Full Text] [Related]
15. Pharmacology of [Tyr1]nociceptin analogs: receptor binding and bioassay studies.
Varani K; Rizzi A; Calo G; Bigoni R; Toth G; Guerrini R; Gessi S; Salvadori S; Borea PA; Regoli D
Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):270-7. PubMed ID: 10543428
[TBL] [Abstract][Full Text] [Related]
16. Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes.
Emmerson PJ; Liu MR; Woods JH; Medzihradsky F
J Pharmacol Exp Ther; 1994 Dec; 271(3):1630-7. PubMed ID: 7996478
[TBL] [Abstract][Full Text] [Related]
17. Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain.
Mansour A; Khachaturian H; Lewis ME; Akil H; Watson SJ
J Neurosci; 1987 Aug; 7(8):2445-64. PubMed ID: 3039080
[TBL] [Abstract][Full Text] [Related]
18. Localization of opioid receptor antagonist [3H]-LY255582 binding sites in mouse brain: comparison with the distribution of mu, delta and kappa binding sites.
Gackenheimer SL; Suter TM; Pintar JE; Quimby SJ; Wheeler WJ; Mitch CH; Gehlert DR; Statnick MA
Neuropeptides; 2005 Dec; 39(6):559-67. PubMed ID: 16289278
[TBL] [Abstract][Full Text] [Related]
19. Affinity labeling of delta opioid receptors by an enkephalin-derivative alkylating agent, DSLET-Mal.
Szatmári I; Orosz G; Medzihradszky K; Borsodi A
Biochem Biophys Res Commun; 1999 Nov; 265(2):513-9. PubMed ID: 10558900
[TBL] [Abstract][Full Text] [Related]
20. Multiple opioid receptors mediate feeding elicited by mu and delta opioid receptor subtype agonists in the nucleus accumbens shell in rats.
Ragnauth A; Moroz M; Bodnar RJ
Brain Res; 2000 Sep; 876(1-2):76-87. PubMed ID: 10973595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
